A growing number of well‐designed epidemiological and molecular studies provide
substantial evidence that the pesticides used in agricultural, commercial, and home and …

Major advances have occurred in our understanding of the biology of multiple myeloma
(MM) and in its treatment in the past decade. New diagnostic criteria have been developed …

Acquired genomic aberrations have been shown to significantly impact survival in several
hematologic malignancies. We analyzed the prognostic value of the most frequent …

Purpose To determine if thalidomide plus dexamethasone yields superior response rates
compared with dexamethasone alone as induction therapy for newly diagnosed multiple …

We report the results of a phase 2 trial using lenalidomide plus dexamethasone (Rev/Dex)
as initial therapy for myeloma. Thirtyfour patients were enrolled. Lenalidomide was given …

Purpose To define patterns of survival among all multiple myeloma (MM) patients diagnosed
in Sweden during a 30-year period. Patients and Methods A total of 14,381 MM patients …

The spectrum of plasma cell disorders is broad. Monoclonal gammopathy of undetermined
significance and smoldering multiple myeloma are asymptomatic disorders characterized by …

Bone is a preferential site for cancer metastases, including multiple myeloma, prostate, and
breast cancers. The composition of bone, especially the extracellular matrix (ECM), make it …

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple
myeloma (SMM) are asymptomatic, pre-malignant disorders characterized by monoclonal …

The type I cryoglobulins (CGs) account for 10–15% of all cryoglobulins and are found in
patients with hematological disorders. We here describe the largest series of seven cases of …